Report copyright - TRILACICLIB (G1T28), A CDK4/6 INHIBITOR, …...• Addition of trilaciclib to chemotherapy (oxaliplatin or 5-FU) and checkpoint inhibitor (anti-PD-1 or anti-PD-L1) combinations enhances
Please pass captcha verification before submit form